首页> 美国卫生研究院文献>Annals of Oncology >P-272The international open-label multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC)

【2h】

P-272The international open-label multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC)

机译：P-272纳布紫杉醇（nab-P）联合吉西他滨（Gem）用于局部晚期胰腺癌（LAPC）的国际开放标签多中心2期LAPACT试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Annals of Oncology
作者
Hammel Pascal; Lacy Jill; Portales Fabienne; Sobrero Alberto; García-Paredes Beatriz; Kim Edward; Rivera Fernando; Manzano Jose Luis; Terrebonne Eric; Bathini Venu; Dowden Scot; Asselah Jamil; Shiansong Li Jack; Nydam Thomas; Kayitalire Louis; Philip Philip;
展开▼
作者单位

展开▼
年(卷),期 -1(27),Suppl 2
年度 -1
页码 ii78–ii79
总页数 1
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
入库时间 2022-08-21 10:50:34

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. APACT: Phase III, Multicenter, International, Open-Label, Randomized Trial of Adjuvant nab-Paclitaxel Plus Gemcitabine (nab-P/G) Versus Gemcitabine (G) for Surgically Resected Pancreatic Adenocarcinoma [J] . Ko A., Reni M., Riess H., Pancreas . 2019,第10期

机译：APACT：辅助Nab-Paclitaxel Plus Gemcitabine（Nab-P / g）的多中心，国际，开放标签，随机试验与吉西他滨（G）用于手术切除胰腺癌
3. APACT: A Phase III Trial of Nab-Paclitaxel (nab-P) Plus Gemcitabine (Gem) Versus Gem Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (PC) [J] . Tempero Margaret, Cardin Dana, Biankin Andrew, The American Journal of Gastroenterology . 2014,第Suppla2期

机译：APACT：Nab-紫杉醇（nab-P）加吉西他滨（Gem）与单独的宝石作为胰腺癌（PC）辅助治疗的III期试验
4. Combination of gemcitabine, nab-paclitaxel, and S-1(GAS) as the first-line treatment for patients with locally advanced or advanced pancreatic ductal adenocarcinoma: study protocol for an open-label, single-arm phase I study [J] . Chen Chang, Xiaofen Li, Dan Cao BMC Cancer . 2021,第1期

机译：吉西他滨，NAB-PABLITAXEL和S-1（天然气）作为局部晚期或晚期胰腺导管腺癌患者的一线治疗：开放标签的研究方案，我研究的单臂阶段
5. Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer [C] . Diana C. Stripp, Rosemarie Mick, Timothy C. Zhu, Conference on optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy . 2004

机译：Matexafin-Lutetium介导的患者局部复发前列腺癌患者的术语I阶段试验
6. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
7. Combination of gemcitabine nab-paclitaxel and S-1(GAS) as the first-line treatment for patients with locally advanced or advanced pancreatic ductal adenocarcinoma: study protocol for an open-label single-arm phase I study [O] . Chen Chang, Xiaofen Li, Dan Cao 2021

机译：吉西滨NAB-PACLITAXEL和S-1（天然气）作为局部晚期或晚期胰腺导管腺癌患者的一线治疗：用于开放标签的研究方案我研究的单臂阶段
8. Phase III, international, multicenter, randomized, open-label trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) alone for surgically resected pancreatic adenocarcinoma (APACT): Subgroup analyses [O] . M.A. Tempero, M. Reni, H. Riess, 2019

机译：佐剂Nab-Paclitaxel Plus Gemcitabine（Nab-P / G）的第III期，国际，多中心，随机，开放标签试验，吉西他滨（G）单独用于手术切除胰腺腺癌（APACT）：亚组分析

P-272The international open-label multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC)

著录项

相似文献

相关主题

期刊订阅